VB Spine Funds Landmark Research for Predictive Blood Test for Scoliosis
VB Spine LLC has partnered with Dr. Alain Moreau at the Centre de recherche Azrieli du CHU Sainte-Justine in Montreal, Canada, to fund research on molecular genetics affecting pediatric scoliosis. This research aims to develop the first predictive blood test for scoliosis in adolescents, aligning with VB Spine’s patient-centered mission to redefine spine care.
NEW YORK–(BUSINESS WIRE)–VB Spine LLC (“VB Spine”), a global, family-owned spine company, today announced that it has entered a partnership to fund research of molecular genetics affecting pediatric scoliosis. The research will be conducted by Dr. Alain Moreau of the Centre de recherche Azrieli du CHU Sainte-Justine, Montreal, Canada. “VB Spine’s mission is specifically centered around the patient: Everything starts with the patient, inspiring us to redefine spine care,” said Marc Viscogliosi
